NPI: 1962458521 · BRYAN, OH 43506 · General Acute Care Hospital · NPI assigned 05/25/2006
Authorized official RISSER, STANTON controls 20+ related entities in our dataset. Read more
| Authorized Official | RISSER, STANTON (ACFO) |
| NPI Enumeration Date | 05/25/2006 |
Other providers sharing the same authorized official: RISSER, STANTON
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 12,906 | $399K |
| 2019 | 12,666 | $427K |
| 2020 | 11,250 | $463K |
| 2021 | 20,799 | $697K |
| 2022 | 27,581 | $976K |
| 2023 | 92,207 | $2.74M |
| 2024 | 49,709 | $1.59M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 12,947 | 11,350 | $1.41M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 7,388 | 5,446 | $867K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 4,286 | 3,208 | $528K |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 3,699 | 2,559 | $463K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2,736 | 2,442 | $281K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 1,136 | 686 | $277K |
| 96361 | Intravenous infusion, hydration; each additional hour | 958 | 600 | $277K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1,134 | 738 | $275K |
| 70450 | Computed tomography, head or brain; without contrast material | 1,133 | 836 | $264K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 4,042 | 3,453 | $253K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 919 | 618 | $218K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 5,087 | 4,242 | $193K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1,815 | 1,663 | $165K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 4,286 | 3,085 | $161K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 1,242 | 588 | $157K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2,464 | 612 | $156K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 1,713 | 543 | $118K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 642 | 361 | $98K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 1,073 | 338 | $83K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 596 | 478 | $81K |
| G0378 | Hospital observation service, per hour | 972 | 531 | $77K |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1,456 | 1,317 | $67K |
| 80048 | Basic metabolic panel (calcium, ionized) | 12,357 | 9,843 | $64K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 319 | 308 | $51K |
| 80053 | Comprehensive metabolic panel | 4,650 | 2,926 | $36K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 120 | 63 | $35K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1,029 | 630 | $33K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 444 | 168 | $30K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 4,727 | 3,917 | $27K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 709 | 551 | $26K |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 377 | 362 | $25K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 105 | 68 | $25K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 230 | 177 | $23K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 17,400 | 12,783 | $22K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 105 | 80 | $20K |
| 64493 | 29 | 25 | $19K | |
| 36415 | Collection of venous blood by venipuncture | 17,183 | 12,681 | $18K |
| 87631 | 111 | 104 | $17K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 441 | 153 | $15K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 1,656 | 1,197 | $14K |
| 71046 | Radiologic examination, chest; 2 views | 1,189 | 904 | $14K |
| 84443 | Thyroid stimulating hormone (TSH) | 1,861 | 1,353 | $13K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 707 | 549 | $13K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 161 | 144 | $13K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 52 | 29 | $13K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 46 | 36 | $11K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 58 | 40 | $11K |
| 71045 | Radiologic examination, chest; single view | 5,912 | 4,844 | $10K |
| 80306 | 1,142 | 745 | $9K | |
| J3490 | Unclassified drugs | 2,791 | 1,190 | $9K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1,120 | 749 | $8K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 64 | 38 | $8K |
| 96367 | 47 | 15 | $7K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 4,422 | 3,138 | $7K |
| 97161 | 148 | 124 | $6K | |
| 85027 | 925 | 699 | $6K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 288 | 196 | $5K |
| 84484 | 3,833 | 2,633 | $5K | |
| 87081 | 908 | 689 | $5K | |
| 80061 | Lipid panel | 446 | 342 | $5K |
| 73562 | 180 | 145 | $5K | |
| 80320 | 681 | 453 | $5K | |
| 73630 | 244 | 199 | $5K | |
| 86140 | 2,066 | 1,470 | $5K | |
| 84439 | 379 | 241 | $4K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 326 | 243 | $4K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 421 | 337 | $4K |
| 80076 | 2,127 | 1,463 | $4K | |
| 81001 | 4,219 | 3,047 | $4K | |
| 82728 | 254 | 180 | $4K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 482 | 345 | $4K |
| 99223 | Prolong inpt eval add15 m | 91 | 81 | $4K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 155 | 151 | $3K |
| 84702 | 200 | 97 | $3K | |
| 84703 | 2,701 | 1,582 | $3K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 50 | 24 | $3K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 148 | 146 | $3K |
| 83735 | 1,750 | 1,119 | $3K | |
| 76830 | Ultrasound, transvaginal | 113 | 82 | $3K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2,028 | 1,326 | $3K |
| 73130 | 102 | 66 | $3K | |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 15 | 14 | $3K |
| 83540 | 289 | 199 | $3K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 130 | 106 | $3K |
| 83605 | 1,318 | 935 | $3K | |
| 73030 | 121 | 95 | $2K | |
| 82607 | 109 | 82 | $2K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2,631 | 1,987 | $2K |
| 85610 | 1,254 | 853 | $2K | |
| 82805 | 47 | 15 | $2K | |
| 83880 | 1,222 | 895 | $2K | |
| 81003 | 1,323 | 910 | $2K | |
| 83550 | 230 | 154 | $2K | |
| 99215 | Prolong outpt/office vis | 35 | 24 | $2K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 95 | 70 | $2K |
| 83690 | 4,079 | 2,852 | $2K | |
| 73610 | 107 | 96 | $2K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 62 | 62 | $2K |
| 82962 | 1,344 | 706 | $1K | |
| 00170 | Anesthesia for intraoral procedures, including biopsy | 13 | 13 | $1K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 14 | 13 | $1K |
| 85379 | 825 | 569 | $1K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 19 | 12 | $1K |
| 87806 | 34 | 27 | $1K | |
| 86592 | 47 | 41 | $1K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 57 | 39 | $1K |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | 13 | 12 | $982.10 |
| 87150 | 17 | 13 | $946.40 | |
| 00731 | 15 | 12 | $892.65 | |
| 96375 | Therapeutic injection; each additional sequential IV push | 2,007 | 1,206 | $870.74 |
| 87186 | 303 | 197 | $865.09 | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 137 | 63 | $843.21 |
| 86850 | 47 | 38 | $804.77 | |
| 93971 | 13 | 12 | $803.57 | |
| 74022 | 339 | 258 | $761.39 | |
| 87077 | 227 | 169 | $668.28 | |
| J7030 | Infusion, normal saline solution , 1000 cc | 6,833 | 3,585 | $632.61 |
| 72100 | 12 | 12 | $620.48 | |
| 85651 | 218 | 160 | $582.02 | |
| 85730 | 961 | 681 | $545.58 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 44 | 27 | $541.85 |
| 72125 | Computed tomography, cervical spine; without contrast material | 43 | 39 | $523.42 |
| 86900 | 92 | 68 | $513.66 | |
| 74018 | 56 | 41 | $435.94 | |
| 96376 | 313 | 161 | $424.80 | |
| 36591 | 143 | 51 | $421.59 | |
| 80055 | 12 | 12 | $410.96 | |
| 73110 | 12 | 12 | $304.87 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 1,907 | 1,232 | $301.29 |
| 87101 | 12 | 12 | $297.25 | |
| J2469 | Injection, palonosetron hcl, 25 mcg | 45 | 14 | $292.90 |
| 82565 | 37 | 34 | $275.75 | |
| 86901 | 92 | 68 | $257.97 | |
| 80143 | 159 | 112 | $252.61 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 769 | 567 | $227.00 |
| 99239 | Hospital discharge day management, more than 30 minutes | 17 | 14 | $213.78 |
| J2704 | Injection, propofol, 10 mg | 4,889 | 2,001 | $195.60 |
| J1170 | Injection, hydromorphone, up to 4 mg | 729 | 360 | $154.56 |
| C9113 | Injection, pantoprazole sodium, per vial | 236 | 118 | $153.16 |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | 202 | 126 | $140.84 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 1,081 | 544 | $123.62 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 629 | 436 | $88.80 |
| 84481 | 27 | 12 | $85.32 | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 492 | 196 | $73.40 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 2,556 | 1,380 | $70.26 |
| 84460 | 614 | 562 | $61.99 | |
| 87040 | 281 | 149 | $58.90 | |
| J7050 | Infusion, normal saline solution, 250 cc | 1,442 | 402 | $50.74 |
| 84450 | 630 | 575 | $48.63 | |
| 82247 | 516 | 471 | $43.15 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 3,825 | 2,056 | $39.44 |
| 84075 | 532 | 484 | $39.35 | |
| 83615 | 14 | 13 | $35.64 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 1,394 | 753 | $34.30 |
| J0690 | Injection, cefazolin sodium, 500 mg | 656 | 313 | $34.05 |
| 80179 | 137 | 97 | $33.02 | |
| 87070 | 40 | 25 | $32.90 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 2,191 | 1,083 | $28.44 |
| J2550 | Injection, promethazine hcl, up to 50 mg | 55 | 27 | $25.32 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 145 | 90 | $21.84 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 548 | 300 | $15.00 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 31 | 16 | $13.50 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 420 | 233 | $10.77 |
| J7799 | Noc drugs, other than inhalation drugs, administered through dme | 29 | 12 | $9.84 |
| C1729 | Catheter, drainage | 28 | 12 | $9.33 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 959 | 637 | $9.00 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 137 | 66 | $2.10 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 817 | 428 | $2.00 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 302 | 164 | $0.34 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 255 | 167 | $0.00 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 247 | 226 | $0.00 |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 25 | 12 | $0.00 |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 208 | 140 | $0.00 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 78 | 72 | $0.00 |
| G8730 | Pain assessment documented as positive using a standardized tool and a follow-up plan is documented | 77 | 76 | $0.00 |
| G9578 | Documentation of signed opioid treatment agreement at least once during opioid therapy | 17 | 16 | $0.00 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 42 | 27 | $0.00 |
| 1006F | 28 | 27 | $0.00 | |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | 296 | 152 | $0.00 |
| 64494 | 29 | 25 | $0.00 | |
| P9612 | Catheterization for collection of specimen, single patient, all places of service | 12 | 12 | $0.00 |
| 88304 | 188 | 88 | $0.00 | |
| A9270 | Non-covered item or service | 44 | 24 | $0.00 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 36 | 35 | $0.00 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 12 | 12 | $0.00 |
| J2060 | Injection, lorazepam, 2 mg | 24 | 13 | $0.00 |
| 82150 | 27 | 19 | $0.00 | |
| J1815 | Injection, insulin, per 5 units | 21 | 12 | $0.00 |